Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Inspections

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive mock FDA inspection services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Inspections

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Business man pushing large stone up to hill , Business heavy tasks and problems concept.

    Unofficial June Mid-Month Peek at ANDA Approval Actions

    Well, we are halfway through June and it’s time to take a look at th...
    Read More
    Red apple with bite

    Another Bite at the Apple!

    Yesterday, U.S. Senators Markwayne Mullin (R-OK) and Cory Booker (D-NJ...
    Read More
    Unofficial May 2025 ANDA Approval Actions - Lachman Blog

    Unofficial May 2025 ANDA Approval Actions—Looks Like a Win!

    Well, another good month for approval actions at the OGD as it keeps t...
    Read More
    FDA Updates Generic Drugs Program Monthly and Quarterly Activities Report - Lachman Blog

    FDA Updates Generic Drugs Program Monthly and Quarterly Activities Report—Big Time

    Well I don’t know whether it was my continued questioning of the whe...
    Read More
    Minor Dosage Form Changes - Lachman Blog

    Minor Dosage Form Changes to OTC Monograph Products Contemplated by Draft FDA Guidance

    Today, the FDA published a draft guidance titled Recommendations for C...
    Read More
    Do More with Less - Lachman Blog

    Do More with Less – Looks Like That Is What the FDA Budget Request Asks

    Now, here is a head scratcher. According to the Pink Sheet article wri...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today